Kim Van der Eecken

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials

Matthew P. Deek, Kim Van der Eecken, Philip Sutera et al. · Journal of Clinical Oncology · 2022 · 243 citations · Full text

Medicine, Oncology, Urology +14

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

Matthew P. Deek, Kim Van der Eecken, Ryan Phillips et al. · European Urology · 2021 · 99 citations · Full text

Medicine, Oncology, Urology +17

Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping

Evan W. Warner, Kim Van der Eecken, Andrew J. Murtha et al. · Nature Cancer · 2024 · 45 citations

Medicine, Oncology, Urology +14

Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma

Lennart Raman, Malaïka Van Der Linden, Kim Van der Eecken et al. · Genome Medicine · 2020 · 44 citations · Full text

Life Sciences, Genetics, Oncology +17

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time

Bert Dhondt, Elise De Bleser, Tom Claeys et al. · World Journal of Urology · 2018 · 34 citations

Medicine, Molecular Biology, Oncology +16